The absence of p21 waf1 combined with an ectopic expression of c-myc prevents ras-induced senescence in mouse embryo fibroblasts. Extension of lifespan after c-myc transduction into p21-null cells was followed at later passages by apoptosis of a large fraction of c-mycoverexpressing p21-null cells. This apoptotic effect could be overridden by inactivation of the p53 tumor suppressor or oncogenic ras expression. Ras-induced inhibition of apoptosis is mediated by PI3K activation. These results suggest a functional relationship between ras and myc that may explain their oncogenic cooperation. The number of foci formed by myc þ ras increased cooperatively in the absence of p21 waf1 . Thus, the reciprocal cooperation between myc and ras in a p21-null background during cellular immortalization lead to increased oncogenic cooperation between ras and myc.
The absence of p21 waf1 combined with an ectopic expression of c-myc prevents ras-induced senescence in mouse embryo fibroblasts. Extension of lifespan after c-myc transduction into p21-null cells was followed at later passages by apoptosis of a large fraction of c-mycoverexpressing p21-null cells. This apoptotic effect could be overridden by inactivation of the p53 tumor suppressor or oncogenic ras expression. Ras-induced inhibition of apoptosis is mediated by PI3K activation. These results suggest a functional relationship between ras and myc that may explain their oncogenic cooperation. The number of foci formed by myc þ ras increased cooperatively in the absence of p21 waf1 . Thus, the reciprocal cooperation between myc and ras in a p21-null background during cellular immortalization lead to increased oncogenic cooperation between ras and myc. Oncogene Keywords: oncogenic cooperation; c-myc; ras; waf1; PI3k
Oncogenic transformation of primary cells through coexpression of ras and 'immortalizing' genes represents a model of multistep tumorigenesis that has been reproduced in vivo (Hunter, 1991; Vogelstein and Kinzler, 1993) . Primary murine fibroblasts lacking p53 pathway are easily established into immortal cell lines (Harvey et al., 1993; Kamijo et al., 1997) and are easily transformed by oncogenic ras (Parada et al., 1984; Serrano et al., 1997) . Oncogenic ras alone transforms murine cells established as lines by spontaneous immortalization (Newbold and Overell, 1983) , although there are some exceptions such as REF52 (Franza et al., 1996) . The induction of a premature senescence programme by oncogenic ras (Serrano et al., 1997) demonstrates the necessity of immortalizing mutations in ras-transformed cells.
Oncogenic Ras provokes cellular senescence via activation of the Raf-MAPK pathway (Lin et al., 1998; Zhu et al., 1998) , which triggers accumulation in growth regulators such as p16INK4a and p21 waf1 (Serrano et al., 1997) . Ras-induced senescence seems to be mediated by tumor suppressor p53 activation, which is regulated by p19 ARF , a molecule also induced by oncogenic transformation of ras (Palmero et al., 1998) . Since p21
waf1 is a transcriptional target of p53, the rasinduced pathway leading to cellular arrest and senescence seems to involve p19
. This is supported by results in different cell lines suggesting that the presence of p21 waf1 is important in maintaining the nontransformed phenotype after oncogenic transformation by ras (Micheli et al., 1996; Missero et al., 1996) .
Aberrant expression of proto-oncogene c-myc is frequently observed in human cancers (Spencer and Groudine, 1991; Henriksson and Luscher, 1996; Amati et al., 1998) . Overexpression of Myc or constitutive activation of Ras is insufficient for cellular transformation. In contrast, coexpression of Myc and activated Ras initiate multiple cell stimulatory activities, induce S phase, and also transform primary embryonic rat fibroblasts (Land et al., 1986; Leone et al., 1997) . The molecular mechanisms responsible for these effects have not yet been sufficiently explored.
Myc, as well as the viral proteins Large T antigen and E1A allow certain primary cells to bypass senescence and become established in culture. The fact that all of these proteins cooperate with Ras supports the hypothesis that cellular immortalization is a prerequisite for full transformation by oncogenic Ras (Weinberg, 1989; Serrano et al., 1997) . The oncogenic cooperation between Ras and Myc has been observed in immortal lines (i.e., Rat1, NIH3T3, Balb/c 3T3, 3Y1), in some established rat diploid cell lines (i.e., REF52) and also in primary rat embryo fibroblasts or baby rat kidney cells (reviewed in Henriksson and Luscher, 1996) . The oncogenic cooperation shared between Ras and Myc in primary mouse embryo fibroblats (MEFs) is not efficient (Latres et al., 2000) and is rarely studied. Activation of Myc and Ras in mice results in synergistic acceleration of tumour formation. Given that these myc þ ras þ tumours occur stochastically and are apparently monoclonal in origin, it seems that additional somatic events are necessary if Myc þ Ras oncogenic transformation in vivo is to occur (Sinn et al., 1987; Langdon et al., 1989; Thompson et al., 1989) .
In our study, we analysed the functional relationship between myc and ras in oncogenic cooperation in MEFs. We examined the effect of these oncogenes in cellular immortalization and also how the absence of the cell cycle inhibitor p21waf1 enhances oncogenic cooperation between ras and myc.
To examine the oncogenic cooperation in presenescent wild-type MEFs, we infected these cells with viruses carrying c-myc and val12-Ras genes. MEFs were infected in passage 2 and drug selected throughout passage 5. Selected cells were plated in passage 5 (immediately preceding senescence) and growth was monitored. Wild-type MEFs expressing oncogenic ras alone did not bypass senescence (Figure 1a) . A small increase (two-fold over the control) in the population was observed in wild-type cells expressing both Ras and Myc. This increase, however, is much lower when compared with Large T antigen þ Ras or the dominant-negative mutant of p53 (175H) þ Ras coexpressions ( Figure 1a ). These results indicate that enforced expression of Myc is not sufficient to fully desensitize MEFs to Ras-induced precocious arrest.
To ensure our protocol of infection and selection results in overexpression of Myc and Ras proteins, we analysed the levels of these proteins under the same conditions. MEFs were infected in passage 2 and the culture was drug selected throughout passage 5. Drug selected mass cultures were analysed for Myc and Ras content (Figure 1b) . We detected overexpression of Myc and Ras coinciding with an induction of p19ARF. It has been reported that this protein is induced by ectopic expression of both proteins (Kamijo et al., 1997; Palmero et al., 1998) .
In contrast to results noted in p53-null cells, absence of p21 waf1 does not inhibit Ras-induced senescence (Pantoja and Serrano, 1999) . Since absence of p21waf1 has been shown to accelerate spontaneous tumorigenesis in mouse models (Weinberg et al., 1995; Missero et al., 1996; Brugarolas et al., 1998; Pantoja and Serrano, 1999; Jones et al., 1999) , we tested whether ras-induced senescence depended upon the coordinated alteration of myc and p21 waf1 . We expressed c-myc in low-passaged p21-null cells (p21 Although the simultaneous inactivation of p21 and enforced expression of Myc bypasses growth arrest during replicative senescence, this does not confer immortalization. A few passages later, around passage 8, c-myc overexpressing p21 À/À MEFs (p21 Figure 2a ). This is due to a high percentage of death by apoptosis at passage 8 until passage 12 (confirmed by FACs and nuclear staining, data not shown). This effect was observed under normal growth conditions, 10% serum. The surviving cells showed a smaller cellular phenotype, can be grown indefinitely and carry mutated alleles of p53 (data not shown). To be sure that the observed crisis was not due to culture selection against myc expression, we analysed the levels of Myc protein at different passages in p21 Figure 1 (a) Myc expression does not bypass ras-induced senescence in wild-type MEFs. Wild-type MEFs were infected with high titer virus containing val12-ras þ vector (O), val12-ras þ p53 (175H) (), val12-ras þ SV40 Large T antigen (W), c-myc þ val12-ras (m). c-myc, SV40 Large T antigen and p53(175H) mutant cDNAs were cloned in pBabepuro retroviral vector. Retroviral-mediated gene transfer was performed as described in Carnero et al. (2000) . PBabe puro-infected cells were selected with 2 mg/ml puromycin. After 4 days of drug selection, at PD 10 (passage 5), 3 Â 10 3 cells were plated in triplicate samples and grown under normal conditions. At the indicated times, cells were fixed and stained with crystal violet. After extensive washing, crystal violet was resolubilized in 10% acetic acid and quantified at 595 nm as a relative measure of cell number. Data are shown as fold of increase. (b) Levels of Myc and Ras proteins in presenescent MEFs following infection and drug selection. Wild-type MEFs were infected with high titer virus containing empty vector (v), val12-ras (ras) or c-myc (myc). After 6 days drug selection, at PD 10 (passage 5), total protein extracts were analysed by Western blot for Ras, myc and p19ARF levels. Immunoblot analysis was performed as previously described (Carnero et al., 2000) . P19ARF was detected using anti-mouse ARF rabbit polyclonal (Ab 80 from AbCam). c-myc was detected using the anti-myc clone 9E11 monoclonal antibody (Ab56 from AbCam). Ras protein was detected using OP41 antibody from Oncogene Science. In all cases, protein was detected using biotinilated secondary antibodies (Amersham) followed by HRPconjugated steptavidin and ECL. (c) p53(175H) mutant or c-myc expression in p21-null cells overrides ras-induced senescence. Wildtype MEFs or p21-null MEFs infected with virus carrying the indicated cDNA (p53 (175H), c-myc or vector alone) were infected with either val12-ras () or vector alone (J) carrying virus. After 3 days of drug selection, at PD 6 (passage 3), 3 Â 10 3 cells were plated in triplicate samples and grown under normal conditions. Cells were fixed daily and the relative growth was measured as before not vary among different passages, including those where crisis was observed (Figure 2b) .
Myc-induced apoptosis in the absence of serum is dependent on functional p53 (Wagner et al., 1994) and we therefore tested whether the apoptotic effect observed in late passages in p21 À/À myc þ þ cells grown at 10% serum was also dependent on wild-type p53. We expressed a construct containing a dominant-negative Levels of phosphorylated Akt in p21-null MEFs following ras infection and drug selection. P21-null MEFs were infected with high titter virus containing empty vector (v), val12-ras (V12), or V12-C40 ras mutant (C40). After 6 days of drug selection, at PD 10 (passage 5), drug-selected cells were cultivated for 24 h in the presence ( þ ) or absence (À) of serum (FBS). Total protein extracts were studied using immunoblot analysis as previously described (Carnero et al., 2000) . Phosphorylated Akt was detected using monoclonal anti-Akt-P (Ab 80 from AbCam) detecting the phosphorylation in ser 473. Total Akt was detected using anti-Akt (#9272 from Cell Signalling) (f) Levels of Akt phosphorylation are maintained throughout late apoptotic crisis in p21 À/À myc þ þ cells overexpressing V12-C40 ras mutant. p21 À/À myc þ þ MEFs were infected with viruses carrying the indicated vector: (v) empty vector, (C40) pWZLblast V12-C40 ras mut. Every 3 days, cells were trypsinized, counted and 10 6 cells plated per 10 cm plate. At indicated passages, levels of phosphorylated Akt protein were analysed from drug-selected mass cultures as described before
Myc-ras cooperation in absence of p21waf1
A Carnero and DH Beach mutant of p53 in early passage p21 À/À myc þ þ MEFs and analysed cell growth. Inhibition of p53 largely blocked apoptosis in these cells (Figure 2c) . Overexpression of Bcl2 partially inhibited apoptosis in late passages p21 (Figure 2c ). Ras activation blocks myc-induced apoptosis (Kauffmann-Zeh et al., 1997; Tsuneoka and Mekada, 2000) and we therefore tested whether oncogenic ras expression was sufficient to block apoptosis observed in p21
We expressed c-myc in low-passaged p21-null cells prior to infection with the ras oncogene. Cells were selected and grown until passage 7 (one passage before apoptotic crisis is usually observed). The cells were then split and their growth was monitored (Figure 2d ). p21-null cells expressing both Myc and oncogenic Ras (p21
The fact that expression of activated Ras can bypass Myc-induced apoptosis in p21-null cells indicates that ras may mimic loss of p53 in this last step before immortalization. This was confirmed by studying the p53 status in immortal clones isolated from p21
In contrast to clones from p21 À/À myc þ þ -derived clones, none of them showed mutated p53 (data not shown).
Thus, oncogenic ras can mimic loss of p53 in p21
It has been reported that Ras inhibits apoptosis induced by myc in the absence of growth factors by activating the PI3K pathway (KauffmannZeh et al., 1997). Finally, we analysed the effect of Ras mutant V12, C40, that activates PI3K as opposed to Raf (Lin et al., 1998) . The expression of this mutant in p21 À/À myc þ þ cells also inhibits the late apoptotic effect (Figure 2d ). We analysed whether ras mutants activate PI3K pathway in our system and whether PI3K pathway was maintained as activated among different passages, including those where crisis was observed. p21 À/À myc þ þ MEFs were infected in passage 2 and the drug was selected throughout passage 5. Drug selected mass cultures were tested for Akt phosphorylation status as an end-point measure of PI3K pathway activation. We detected an increase in Akt phosphorylation coinciding with ras infection and these levels were insensitive to serum depletion (Figure 2e) . Furthermore, the levels of Akt phosphorylation did not vary among different passages, including those where crisis was observed (Figure 2f) .
We have shown that coordinated absence of p21waf1 and enforced expression of c-myc can collectively inhibit ras-provoked MEFs arrest. Moreover, activated ras inhibits the late crisis that appears in Myc-expressing p21-null cells through the activation of PI3K, compensating for myc-induced apoptosis and removing the need to mutate p53, a similar finding previously reported in a different context (Kauffmann-Zeh et al., 1997) . This reciprocal effect during immortalization might explain the oncogenic cooperation between myc and ras. Furthermore, it suggests that in p21-null MEFs, these oncogenes might have enhanced transforming cooperation.
Oncogenic Ras activates p53 that leads to an increase in p21 waf1 , and absence of p53 renders the cells insensitive to oncogene-induced arrest. To study the possible role of p21 waf1 in c-myc-ras cooperation, we firstly analysed the effect of p21waf1 loss on the ability À /ts cell line (from a p53 knockout mice expressing the 135 val termosensible mutant of p53) was described by Carnero et al. (2000) . A p21-null cell line (p53 À ;p21 À /ts) was generated following the same procedure, using MEFs from a p21;p53 double knockout. To generate versions of these cell lines overexpressing oncogenic ras, a Val12-Hras mutant was cloned into pWZlblast. P53
À /ts and p53 À ;p21 À /ts cell lines were infected with retrovirus carrying oncogenic ras or vector alone and selected for the expression marker (1 mg/ml blasticidin, from Sigma). The generated lines (p53 À /ts/ras and p21 À ;p53 À /ts/ras) were tested for ras expression. The p53 À /ts and p21 À ;p53 À /ts cells or the derived cell lines expressing oncogenic ras were infected with virus carrying c-myc. After selection, 10 4 cells were plated in a 10 cm dish and grown at restrictive temperature to activate p53. After 12 days, the cells were fixed, stained and colonies were counted. Results show the average of the mean of three independent experiments performed in triplicate. (b) Ras cooperates with c-myc in foci formation in p21-null background. p21-null cells at 50% confluence were infected at passage 4 with c-myc or p53 mutant (175H) or in combination with ras val12 . Cells were cultivated for 15 days without selection changing medium every 3 days. At this point, plates were stained with crystal violet and washed extensively. (c) Absence of p21 enhances myc þ ras oncogenic cooperation. p21-null or wild-type MEFs at 50% confluence were coinfected at passage 4 with c-myc and ras val12 . c-myc virus supernatant (5 ml) was used in all the infections. Different volumes of ras virus supernatant were used to establish the different dilution: 10 ml (1 : 2 dilution), 5 ml (1 : 1), 1 ml (1 : 0.2), and 0.5 ml (1 : 0.1). Fresh medium was added up to 15 ml in all plates. Cells were cultivated for 15 days without selection, changing medium every 3 days. At this point, plates were stained with crystal violet and washed extensively. All the cells were infected with the same supernatant pools. Results show the average number of foci per 10 cm dish in two independent experiments performed in triplicate Myc-ras cooperation in absence of p21waf1 A Carnero and DH Beach to bypass p53-dependent arrest. To this end, we generated several cell lines derived from p53 nullizygous MEFs expressing the temperature-sensitive mutant of p53. The cell lines were selected and grown at 391C -a temperature at which p53 is inactive. These cells grew actively at 391C but arrested at 321C (Carnero et al., 2000) .
The absence of p21 waf1 does not compensate for the activation of p53, and p21-null cells still arrest after the activation of p53 even with activated Ras (Figure 3a) . Ectopic expression of Myc partly bypasses p53-induced arrest (Figure 3a) . Approximately 50% of the cells expressing Myc bypass p53 arrest. With Ras present, however, the percentage of Myc-expressing cells that can form colonies at a restrictive temperature is reduced to 20% (Figure 3a) . In the absence of p21 waf1 , the number of colonies expressing Myc that bypass p53 arrest increases compared to wild-type background. This bypass is also observed in cells expressing oncogenic ras. In both cases, approximately 80% of cells bypass p53-induced arrest (Figure 3a) .
Myc is involved in CDK2 activity through activation of cyclins E and A (Jansen-Du¨rr et al., 1993; Steiner et al., 1995; Rudolph et al., 1996) and the inactivation of p27 kip1 (Vlach et al., 1996; Perez-Roger et al., 1997) . The fact that myc requires the absence of p21 waf1 to fully bypass the p53-induced arrest or the arrest induced by p53 and Ras (Figure 3a ) may indicate that inactivation of p21 waf1 is another necessary step for the full activation of CDK2. Some reports have shown a downregulation of p21 waf1 by myc in different systems (Ceballos et al., 2000; Wu et al., 2003) . We have not observed a significant reduction of p21 waf1 levels in wild-type MEFs infected with c-myc-carrying viruses (not shown).
These data suggest that the oncogenic cooperation mechanism is partly dependent on the presence of p21 waf1 , and that its absence has an enhanced effect on transformation.
Foci formation, as a measure of cellular transformation, could not be achieved by ras alone (Pantoja and Serrano, 1999) nor by ectopic expression of c-myc in p21 waf1 -null MEFs (Figure 3b ). Coordinated expression of Myc and Ras in p21-null cells however form foci as efficiently as coexpression of p53 mutant and Ras (Figure 3b) . To compare the efficiency of foci formation in both backgrounds, wild type versus p21 null, we coinfected these MEFs with the same amount of viruses carrying myc and serial dilutions of viruses carrying oncogenic ras (Figure 3c ). At high concentrations of both viruses, sporadic foci were formed in wild-type MEFs, but not at low concentrations of Ras. In a p21-null background, a high number of foci were formed even at very low dilutions of ras-containing viruses (Figure 3c ). These results indicate that absence of p21 waf1 enhances myc þ ras oncogenic cooperation in mouse embryo fibroblasts.
Although p21 waf1 -null mice show a certain predisposition to spontaneous tumor formation (Martin-Caballero et al., 2001) , the absence of p21 waf1 leads to increased oncogenic cooperation between ras and myc. In line with this, absence of p21 waf1 accelerates spontaneous tumorigenesis combined with other mutations such as in pRb (Brugarolas et al., 1998) , INK4a/ARF D2,3 (Pantoja and Serrano, 1999) or Wnt-1 (Jones et al., 1999) . Furthermore, a number of studies have suggested p21 waf1 involvement in keratinocyte growth control (Weinberg et al., 1995; Missero et al., 1996) skin tumorigenesis, both chemically induced or in response to oncogenic ras alone in mice (Missero et al., 1996; Weinberg et al., 1999; Philipp et al., 1999; Topley et al., 1999) .
The reciprocal effect during immortalization between the absence of p21 waf1 , and presence of c-myc and Ras contributes to increased oncogenic cooperation and proves sufficiently effective to produce full oncogenic transformation of mouse embryo fibroblasts. This underlines an important role for p21 waf1 as a tumor suppressor whose absence is necessary but not sufficient alone for transformation and needs to be complemented by another signal (such as c-myc expression) in order to develop the loss of function effect in tumors.
